API | alpha-ethyltryptamine

alpha-ethyltryptamine Report issue

Small molecule Experimental

ChEMBL DrugBank Drug Central KEGG PubChem

Active Ingredient History

ETRYPTAMINE (MONASE®), similar to the hallucinogenic tryptamines, is an inhibitor of monoamine oxidase, introduced for use as an antidepressant. It was withdrawn from the market due to problems with agranulocytosis and other side effects. However, it's activity is still under scientific investigation. ^NCATS

Chemistry

SMILES: CCC(N)Cc1c[nH]c2ccccc12
InChIKey: ZXUMUPVQYAFTLF-UHFFFAOYSA-N
Mol. Mass: 188.27
ALogP: 2.45 Partition coefficient
ChEMBL Molecules:

etryptamine

etryptamine acetate

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

alpha-ethyltryptamine | ethyltryptamine | etryptamine | etryptamine acetate

Indications (1)

Approved Indications (1)

Depression (approved 1961)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue